Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | CASP6 | P55212 | 1/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | F2 | P00734 | 2/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28267944 | 0.98 | ELANE (0.47) | ELANETDP1KDM4EGLAGAA | |
| SCHEMBL15679080 | 0.92 | ELANE (0.55) | ELANEMAPTPARP10CYP3A4CYP1A2 | |
| SCHEMBL23493150 | 0.92 | ELANE (0.55) | ELANEMAPTPARP10CYP3A4CYP1A2 | |
| Hydrochloric Acid SCHEMBL30184762 | 0.90 | ELANE (0.53) | ELANEMAPTPARP10CYP3A4CYP1A2 | |
| SCHEMBL20472709 | 0.86 | SMN1; SMN2 (0.50) | ELANEKDM4EMAPTTHRBPRSS1 | |
| SCHEMBL4683823 | 0.86 | ELANE (0.66) | ELANETDP1KDM4EGLAGAA | |
| SCHEMBL3128225 | 0.84 | ELANE (0.48) | ELANETDP1KDM4EGLAGAA | |
| Hydrochloric Acid SCHEMBL27456547 | 0.84 | ELANE (0.63) | ELANETDP1KDM4EGLAGAA | |
| SCHEMBL15679089 | 0.84 | ELANE (0.48) | ELANETDP1KDM4EGLAGAA | |
| SCHEMBL3199570 | 0.84 | ELANE (0.48) | ELANEGAAPARP10CYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2025-11-06 | — | — | US | claimed |
| EP-4448544-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2024-10-23 | — | — | EP | claimed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | claimed |
| US-20210206835-A1 | Self-Assembling Collagen-Like Polypeptides for Applications and Uses Related Thereto | NATIONAL SCIENCE FOUNDATION | 2021-07-08 | — | — | US | claimed |
| EP-3788149-A1 | A METHOD FOR OPTIMIZING ANTIBODY EXPRESSION | Ambrx, Inc. (US) | 2021-03-10 | — | — | EP | claimed |
| US-20190135865-A1 | AGONIST AGENTS OF CD47 INDUCING PROGRAMMED CELL DEATH AND THEIR USE IN THE TREATMENTS OF DISEASES ASSOCIATED WITH DEFECTS IN PROGRAMMED CELL DEATH | SORBONNE UNIVERSITE (FR) | 2019-05-09 | — | — | US | claimed |
| EP-3454880-A1 | AGONIST AGENTS OF CD47 INDUCING PROGRAMMED CELL DEATH AND THEIR USE IN THE TREATMENTS OF DISEASES ASSOCIATED WITH DEFECTS IN PROGRAMMED CELL DEATH | SORBONNE UNIVERSITE (FR) | 2019-03-20 | — | — | EP | claimed |
| WO-2017194634-A1 | AGONIST AGENTS OF CD47 INDUCING PROGRAMMED CELL DEATH AND THEIR USE IN THE TREATMENTS OF DISEASES ASSOCIATED WITH DEFECTS IN PROGRAMMED CELL DEATH | UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (FR) | 2017-11-16 | — | — | WO | claimed |
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL LLC (US) | 2016-09-08 | — | — | US | claimed |
| CN-104470524-A | Ghrelin receptor agonists for the treatment of achlorhydria | RAQUALIA PHARMA INC | 2015-03-25 | — | — | CN | claimed |
| EP-2262763-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2010-12-22 | — | — | EP | claimed |
| CN-101674853-A | Amino acid lipids and uses thereof | NASTECH PHARM CO | 2010-03-17 | — | — | CN | claimed |
| WO-2009109973-A2 | COMPOUNDS AND METHODS OF TREATING OBESITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-11 | — | — | WO | claimed |
| CN-100423772-C | Stabilization of pharmaceutical protein formulations with small peptides | BAXTER INT (US) | 2008-10-08 | — | — | CN | claimed |
| CN-101060885-A | Treating depressive disorders with carbonic anhydrase activators | BRNI NEUROSCIENCES INST (US) | 2007-10-24 | — | — | CN | claimed |
| CN-1791420-A | Treatment of T-cell mediated diseases | DMI BIOSCIENCES INC (US) | 2006-06-21 | — | — | CN | claimed |
| CN-1674899-A | Use of IkappaB-kinase inhibitors in pain therapy | AVENTIS PHARMA GMBH (DE) | 2005-09-28 | — | — | CN | claimed |
| CN-1549722-A | Anti-cancer and wound healing compounds | 金伯利-克拉克环球有限公司 | 2004-11-24 | — | — | CN | claimed |
| EP-0225503-B1 | RESOLUTION SYSTEM | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1989-08-02 | — | — | EP | claimed |
| EP-0225503-A1 | Resolution system | YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED (IL) | 1987-06-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160257643-A1 | AMINO ACID DERIVATIVES AND ABSORBABLE POLYMERS THEREFROM | SRRM2, SLC7A1, BCAT2 | ELANE 3207/4885TDP1 1961/4885KDM4E 2679/4885 |
| US-20190135865-A1 | AGONIST AGENTS OF CD47 INDUCING PROGRAMMED CELL DEATH AND THEIR USE IN THE TREATMENTS OF DISEASES ASSOCIATED WITH DEFECTS IN PROGRAMMED CELL DEATH | CD47, BID, CD274 | ELANE 2006/4885TDP1 2790/4885KDM4E 2174/4885 |
| US-20250339569-A1 | CARBONIC ANHYDRASE IX LIGANDS | CA9, CA13, CA4 | ELANE 2918/4885TDP1 4334/4885KDM4E 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.